-
Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Why is Amgen IC so bad?
- Thread starter anonymous
- Start date
-
- Tags
- None
It’s crazy that a company like Amgen has ONE guy in charge of incentives and zero clue what he’s doing. The new incentive guy in cv who changed the entire IC plan left and now there is no one in the department to help with the major issues. It’s insane. Rankings are a total joke and so is the IC plan. Any time we identify real issues and show data that is missing or inconsistencies they will once in a while admit the issue but say nothing can be done this quarter, they’ll rectify it next time….I’m sorry whaaaaat?! We are salespeople. This is how we get paid and ranked. It’s infuriating
. Pure incompetence.
How is the new guy Tim brought in working out??
Same target payout as a decade ago with 1970’s inflation, so not so good!
bring back the old CV IC guy. He cared about the sales team. Heard he was a rep before and did a pretty OK job and can answer questions. After cliffie made his archaic DM bud do cv ic, I’m almost sure he was more confused than Biden being president at his age. Not sure we have anyone now. No presence and no communication
Now that Timmy isn't running rough overtop of the IC bozos, look for things to get worse and worse. We've all accepted that IC is a maze of falsehoods, especially for INBU, but with Timmy gone, it's gonna get a lot worse.
The data is unreliable, baselines make zero sense, and nobody can understand all of the nuances that go into the numbers
sounds like a recipe for success!
sounds like a recipe for success!
Well in derm, we now reward those that sell the least in the contest. The names atop the list are jokes!
Rep Activity Master goes from 1 to 2 scripts (100% growth) and makes more money than
Rep Long Term Performer who goes from 950 to 1000 scripts ( 5% growth).
We are paying the wrong people.
Rep Activity Master goes from 1 to 2 scripts (100% growth) and makes more money than
Rep Long Term Performer who goes from 950 to 1000 scripts ( 5% growth).
We are paying the wrong people.
in Rheum the payout curves for SGA have been so flattened that we don't care - it's more important to make your call numbers than actually sell - that's what counts at calibration
why hustle when IC can't accurately track anything anyway?
hate to generalize but the asians good at math people are doing IC right and the teams that have good plans with good explanations are the ones that can do math.
Derm is being transformed into an entirely metrics/KPI driven machine. Amgen IC has a track record of screwing up about every other report be it weeklies, CDRs or contests reports. No one trusts anything they produce.
What's important come calibration is call metrics. Consider the following:
Rep XYZ: great sales performance but call metrics off because they "overcall" on the people they can actually see and don't fake calls on the no-sees or dead docs. Their calibration is brought down as a result. EVERY SINGLE TIME!
Rep ABC: below average sales performance but call metrics look like a Swiss clock. Everyone, regardless of dead or alive, retired or working in dentistry, has call plan achieved perfectly. Their calibration is brought up. EVERY SINGLE TIME!
This is a metrics driven operation because that's what the EDs of sales and marketing can sell Ian/Lucky Charms/Big Bob.
Spin it anyway you want to claim it's not so, but it's TRUTH.
What's important come calibration is call metrics. Consider the following:
Rep XYZ: great sales performance but call metrics off because they "overcall" on the people they can actually see and don't fake calls on the no-sees or dead docs. Their calibration is brought down as a result. EVERY SINGLE TIME!
Rep ABC: below average sales performance but call metrics look like a Swiss clock. Everyone, regardless of dead or alive, retired or working in dentistry, has call plan achieved perfectly. Their calibration is brought up. EVERY SINGLE TIME!
This is a metrics driven operation because that's what the EDs of sales and marketing can sell Ian/Lucky Charms/Big Bob.
Spin it anyway you want to claim it's not so, but it's TRUTH.
That's where call flexing comes in to play. The real survivors at Amgen know how to work call flexing so that they give TO exactly what they want. It's worked wonders for the KPI dashboard for brands like Enbrel and Aimovig. Sales, not so much, but boy of boy do the KPIs around calls look great!
Watch and learn. Those skilled with call flexing are the same ones skilled with spectacular coaching reports, marvelous success story emails, and talk a lot on all-staff calls, but have a history of not winning anything at sales. You will learn derm reps. No one likes you anyway.
You will do nothing but hit the emoji button on calls and fake your coaching reports cuck.
How are we suppose to be motivated if Amgen IC is so complicated? I just show up and pray I get a bonus check sometimes.